What is the appropriate clobazam dosage for treating status epilepticus in adults and children (≥2 years), including loading and maintenance doses?

Clobazam is NOT a standard treatment for status epilepticus

Clobazam is FDA-approved only for adjunctive treatment of Lennox-Gastaut syndrome seizures, not for status epilepticus. The available evidence does not support its use as a primary agent in status epilepticus management 1.

Critical Evidence Gap

The provided guidelines for status epilepticus management 2, 3, 2, 3 consistently recommend lorazepam, midazolam, or diazepam as first-line benzodiazepines, with second-line agents including levetiracetam, phenobarbital, valproate, or fosphenytoin. Clobazam is conspicuously absent from all status epilepticus treatment algorithms.

Why Clobazam is Not Used in Status Epilepticus

Clobazam is an oral-only formulation (2.5 mg/mL suspension) 1, making it impractical for acute status epilepticus where:

• Rapid IV/IM administration is essential
• Patients often cannot safely swallow
• Time to therapeutic effect is critical for preventing neuronal injury

The 1,5-benzodiazepine structure of clobazam, while advantageous for chronic epilepsy management (less sedation, better tolerability), does not provide the rapid seizure termination needed in status epilepticus 4.

Limited Evidence for Clobazam in Status Epilepticus

A systematic review found only 76 reported cases of clobazam use in status epilepticus, with a 47% remission rate when introduced 2-4 days after SE onset at doses of 10-60 mg/day 4. However:

• These were retrospective, uncontrolled observations
• Clobazam was used as an add-on, not primary therapy
• Introduction occurred days into the episode, not acutely
• The evidence is insufficient to determine safety and efficacy 4

One small study from 1984 reported single oral doses averaging 1.0 mg/kg stopped certain non-convulsive status epilepticus types in 19-31 minutes 5, but this has not been replicated or validated in modern practice.

Standard Status Epilepticus Treatment (What You Should Use Instead)

Pediatric Convulsive Status Epilepticus 3:

• Lorazepam 0.1 mg/kg IV (maximum 2 mg); repeat after ≥1 minute (maximum 2 doses)
• Levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg)
• If persistent: Phenobarbital 10-20 mg/kg IV (maximum 1,000 mg)

Pediatric Non-Convulsive Status Epilepticus 3:

• Lorazepam 0.05 mg/kg IV (maximum 1 mg); repeat every 5 minutes (maximum 4 doses)
• Levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg)
• If persistent: Phenobarbital 10-20 mg/kg IV (maximum 1,000 mg)

Adult Status Epilepticus 6:

• First-line: Benzodiazepines (lorazepam preferred)
• Second-line: Levetiracetam 30 mg/kg IV at 5 mg/kg/min, valproate 30 mg/kg IV, or fosphenytoin 18 mg/kg IV
• Refractory: Midazolam 0.15-0.20 mg/kg IV loading dose, then continuous infusion 2

Common Pitfalls

• Do not delay IV benzodiazepines to attempt oral clobazam administration
• Do not confuse clobazam's role in chronic epilepsy (where it is effective) with acute status epilepticus management
• Do not use clobazam as a substitute when standard IV benzodiazepines are unavailable—seek alternative IV agents instead

Bottom Line

There is no established dosing regimen for clobazam in status epilepticus because it should not be used for this indication. Use IV lorazepam, midazolam, or diazepam as first-line agents, followed by IV levetiracetam, valproate, phenobarbital, or fosphenytoin as per established guidelines 2, 3, 2, 6, 3, 6. Clobazam remains an excellent adjunctive oral agent for chronic seizure management, particularly in Lennox-Gastaut syndrome 1, but has no role in acute status epilepticus treatment.